This announcement is a separate document:
宁波美诺华药业股份有限公司关于控股子公司精氨酸培哚普利原料药通过CDE技术审评的公告
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the holding subsidiary arginine perindopril API passing the CDE technical review
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.